Enter Note Done
Go to previous page in this tab
Event
  • Continuing Education Course
  • Bookmark Icon
  • AM08: Pulling Back the Curtain: AI/ML for Pharmaceutical Toxicologists with Hands-On Examples
  • Schedule
    Notes
  • Set Timezone

Primary Endorser: Computational Toxicology Specialty Section


Endorser(s): Drug Discovery Toxicology Specialty Section


Artificial intelligence and machine learning (AI/ML) are increasingly being incorporated into pharmaceutical research and development; however, their practical application in toxicology remains variable. While many toxicologists are familiar with AI/ML concepts, there is often a gap between awareness and implementation. This course is designed to address this gap by providing a structured, applied introduction to how AI/ML approaches can support real-world toxicological decision-making.

This course focuses on a common and challenging problem in pharmaceutical toxicology: the interpretation and translation of gastrointestinal (GI) toxicity findings observed in nonclinical dog studies to potential human risk. GI findings—including vomiting, diarrhea, decreased food intake, and histopathological evidence of mucosal injury—are frequently observed in repeat-dose toxicity studies in dogs, the primary nonrodent species used in regulatory safety assessment. However, their relevance to human safety is often uncertain. These findings may reflect local irritation, exaggerated pharmacology, off-target effects, formulation-related factors, or species-specific sensitivities. Determining their translational significance is critical for informing development decisions, including whether to progress a compound, modify formulation or dosing, or implement clinical monitoring strategies.

This course uses this translational challenge as a unifying framework to demonstrate how AI/ML approaches can be applied to integrate heterogeneous data sources, extract information from unstructured text, and support more consistent and transparent decision-making. The course is organized into four sequential sessions, each focusing on a distinct class of AI/ML methods. All sessions are anchored to a shared case study involving a hypothetical compound (“Compound X”) associated with GI toxicity findings in dog repeat-dose studies. This structure allows participants to directly compare how different analytical approaches influence interpretation and decision-making.

A defining feature of this course is its hands-on, interactive format. Each session includes a practical component in which participants will work in real time with pre-configured Jupyter notebooks and curated mock datasets that reflect realistic nonclinical and translational data. The notebooks will be fully set up in advance and designed for accessibility, requiring no prior programming experience. Participants will be guided through step-by-step workflows, including model development, data extraction, integration, and scenario analysis.

The first session introduces interpretable machine learning approaches for early signal detection and triage. Participants will explore how structured datasets derived from nonclinical studies can be used to train models that estimate the likelihood that dog GI findings are relevant to humans. Methods such as logistic regression and tree-based models will be used to illustrate how predictive performance can be balanced with interpretability.

The second session addresses the challenge of unstructured toxicology data. Toxicology reports and pathology narratives contain detailed observations that are not consistently captured in structured datasets. This session demonstrates how natural language processing (NLP) approaches can be used to extract and standardize this information into features suitable for analysis.

The third session focuses on multimodal data integration. Participants will explore how AI/ML approaches can combine diverse data types—including nonclinical findings, pharmacokinetics, and biological context—into a unified analytical framework to improve interpretation of toxicity signals.

The final session introduces causal inference and counterfactual analysis to support decision-making. Participants will evaluate how changes in exposure, formulation, or dosing strategy may influence GI toxicity risk using scenario-based approaches.

Throughout the course, emphasis is placed on practical application, transparency, and critical evaluation. Participants will consider both the capabilities and limitations of AI/ML approaches and their appropriate use in toxicology.



IAT ITS Designation: Innovations in Applied Toxicology (IAT),Innovations in Toxicological Sciences (ITS)
Session and Activity Type
Presentations